Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

被引：0
|
作者：
Giovanni Battista Bolla
Antonella Fedele
Andrea Faggiano
Carla Sala
Gloria Santangelo
Stefano Carugo
机构：
[1] University of Milan and Fondazione IRCCS Ca’ GrandaOspedale Maggiore Policlinico,Department of Clinical Sciences and Community Health
[2] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Cardiology Unit, Internal Medicine Department
[3] University of Milan,Division of Cardiology, Department of Health Sciences, San Paolo Hospital
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
Heart failure; Sacubitril/Valsartan; Biomarkers; Fibrosis; Left ventricular ejection fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction
    Bolla, Giovanni Battista
    Fedele, Antonella
    Faggiano, Andrea
    Sala, Carla
    Santangelo, Gloria
    Carugo, Stefano
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [2] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [3] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [4] Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction
    Vitale, Giuseppe
    Romano, Giuseppe
    Di Franco, Antonino
    Caccamo, Giuseppa
    Nugara, Cinzia
    Ajello, Laura
    Storniolo, Salvo
    Sarullo, Silvia
    Agnese, Valentina
    Giallauria, Francesco
    Novo, Giuseppina
    Clemenza, Francesco
    Sarullo, Filippo M.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [5] Effects of sacubitril-valsartan on central and obstructive apneas in heart failure patients with reduced ejection fraction
    Wang, Youmeng
    Branco, Roberto Fernandes
    Salanitro, Matthew
    Penzel, Thomas
    Schobel, Christoph
    SLEEP AND BREATHING, 2023, 27 (01) : 283 - 289
  • [6] Effects of sacubitril-valsartan on central and obstructive apneas in heart failure patients with reduced ejection fraction
    Youmeng Wang
    Roberto Fernandes Branco
    Matthew Salanitro
    Thomas Penzel
    Christoph Schöbel
    Sleep and Breathing, 2023, 27 : 283 - 289
  • [7] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [8] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [9] Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review
    Zhirov, Igor V.
    Safronova, Natalia V.
    Tereshchenko, Sergey N.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (09) : 802 - 809
  • [10] Efficacy and Dosage Pattern of Sacubitril/Valsartan in Chinese Heart Failure with Reduced Ejection Fraction Patients
    Cheang, Iokfai
    Shi, Shi
    Lu, Xinyi
    Liao, Shengen
    Zhu, Xu
    Su, Xi
    Lu, Qi
    Yuan, Jing
    Xu, Dachun
    Zhang, Min
    Dai, Cuilian
    Wang, Jingfeng
    Yuan, Fang
    Zhao, Yan
    Zhou, Jingmin
    Li, Xinli
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (05) : 1192 - 1202
12345